Literature DB >> 20406920

Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer.

Dimitrios H Roukos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20406920     DOI: 10.1200/JCO.2009.27.7061

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  24 in total

1.  Personalized medicine for laparoscopic gastrectomy in gastric cancer.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-05-02       Impact factor: 4.584

2.  Expanding laparoscopic gastrectomy for gastric cancer outside Korea and Japan.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-06-26       Impact factor: 4.584

3.  Predictive medicine and esophageal cancer response to preoperative chemotherapy.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-06-22       Impact factor: 4.584

4.  Optimizing locoregional staging in the preoperative setting of resectable esophageal cancer.

Authors:  Charalambos Batsis; Ioannis Makris
Journal:  Surg Endosc       Date:  2011-04       Impact factor: 4.584

5.  Advances and high demands in totally robotic surgery for rectal cancer.

Authors:  Christos Katsios; Georgios Baltogiannis
Journal:  Surg Endosc       Date:  2011-05       Impact factor: 4.584

6.  Cost-effectiveness analyses of laparoscopic versus open surgery.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2011-03       Impact factor: 4.584

7.  Extraperitoneal rectal cancer: why laparoscopic may be more effective than open surgery.

Authors:  John Spiliotis; Odysseas Zoras
Journal:  Surg Endosc       Date:  2011-02       Impact factor: 4.584

8.  Minimally invasive esophagectomy.

Authors:  Theodore Liakakos
Journal:  Surg Endosc       Date:  2010-07-22       Impact factor: 4.584

9.  From evidence to a day-to-day laparoscopic colectomy.

Authors:  Ernst Hanisch; Dimosthenis E Ziogas
Journal:  Surg Endosc       Date:  2011-03       Impact factor: 4.584

10.  To resect or not the primary tumor in metastatic colorectal cancer.

Authors:  Christos G Katsios; Georgios Baltogiannis
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.